Memphis, TN – According to filings with the U.S. Securities and Exchange Commission, Triad Life Sciences is raising $4,995,904.00 in new funding. Sources indicate as part of senior management Chief Legal Officer, Donna Best played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Triad Life Sciences

Triad Life Sciences is a science-driven, patient-focused biotech company dedicated to the innovation of tissue-based solutions for the treatment of acute or chronic wounds, soft tissue injuries, and other regenerative applications. Triad is diligent in its commitment to providing best-in-class solutions to address inherent problems with Extracellular Matrixes (ECMs) through our breakthrough material science platform.

To learn more about Triad Life Sciences, visit http://www.triadls.com/

Contact:
Donna Best, Chief Legal Officer
901-333-6000

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved